Toggle light / dark theme

The Breakthrough Starshot is an effort backed by US$100 million from Russian investor Yuri Milner to vastly accelerate research and development of an interstellar space probe.

Leaders of the mission plan to start funding technology-development projects within months, with the aim of launching a fleet of tiny, laser-propelled probes in the next 20 years. The effort would ultimately cost about $10 billion, leaders hope, and take another 20 years to reach Alpha Centauri.

The first truly challenging step in any mission such as Breakthrough Starshot is to accelerate the spacecraft to interstellar velocities.

Read more

To learn more about Breakthrough Starshot, visit http://breakthroughinitiatives.org.

On the fifty-fifth anniversary of Yuri Gagarin’s great leap into space, April 12, 2016, Yuri Milner was joined by Stephen Hawking at New York’s One World Observatory to announce Breakthrough Starshot, which will lay the foundations for humanity’s next great leap: to the stars. It was also announced that Mark Zuckerberg joined the board of the initiative.

Breakthrough Starshot is a $100 million research and development program, aiming to establish proof of concept for a ‘nanocraft’ – a fully functional space probe at gram-scale weight – driven by a light beam. A spacecraft like this, equipped with a lightsail, has the potential to reach twenty percent of the speed of light – or 100 million miles an hour. At that speed, it could reach Alpha Centauri, our nearest star system, in around 20 years. Using the fastest conventional rocket propulsion system available, the same journey would take tens of thousands of years.

This new scientific initiative is committed to international collaboration, open access and open data. It aims to represent all of humanity as one world, stepping out into the galaxy within a generation.

Pterostilbene showing some interesting potential for treating cancer.


One of the most common forms of cancer in the hematologic system is Multiple myeloma (MM) which affects plasma cells, a type of white blood cell that produces antibodies. With advanced symptoms bone pain, bleeding, frequent infections, and anemia may occur.

In studies, Pterostilbene has shown anti-inflammatory and anticarcinogenic properties which has led to the improved function of healthy cells and the inhibition of malignant cells. So far its anticarcinogenic action has been reported for lung, breast and prostate cancers. Today we will look at the latest research showing how it could be used to treat cancer patients.

A better Resveratrol